当前位置:首页 - 行情中心 - 步长制药(603858) - 财务分析 - 现金流量表

步长制药

(603858)

  

流通市值:171.68亿  总市值:171.68亿
流通股本:10.55亿   总股本:10.55亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,431,477,425.4411,197,877,205.878,100,939,408.25,751,891,144.21
  收到的税费返还163,994.4135,400.57--
  收到其他与经营活动有关的现金28,728,739.4557,034,784.06177,641,989.9793,283,141.65
  经营活动现金流入小计2,460,370,159.311,254,947,390.58,278,581,398.175,845,174,285.86
  购买商品、接受劳务支付的现金822,743,873.253,003,227,701.432,063,410,259.461,315,040,484.68
  支付给职工以及为职工支付的现金237,528,806.34956,051,118.68747,045,197.46477,127,688.87
  支付的各项税费415,025,262.921,276,824,161.72955,721,908690,743,306.72
  支付其他与经营活动有关的现金1,020,519,485.474,861,057,333.823,697,312,120.542,403,294,446.88
  经营活动现金流出小计2,495,817,427.9810,097,160,315.657,463,489,485.464,886,205,927.15
  经营活动产生的现金流量净额-35,447,268.681,157,787,074.85815,091,912.71958,968,358.71
二、投资活动产生的现金流量:
  收回投资收到的现金6,87599,036,147.258,800,0008,800,000
  取得投资收益收到的现金107,166,582.287,239,731.575,414,940.383,705,542.51
  处置固定资产、无形资产和其他长期资产收回的现金净额167,346.8214,262.2211,710240,290
  收到的其他与投资活动有关的现金785,642.674,902,108.814,236,249.913,093,462.1
  投资活动现金流入小计108,126,446.75111,392,249.8318,662,900.2915,839,294.61
  购建固定资产、无形资产和其他长期资产支付的现金16,603,343.12123,424,399.4185,697,216.5462,977,434.91
  投资支付的现金240,940,48030,000,000286,924,270178,100,000
  支付其他与投资活动有关的现金218,002.72---
  投资活动现金流出小计257,761,825.84153,424,399.41372,621,486.54241,077,434.91
  投资活动产生的现金流量净额-149,635,379.09-42,032,149.58-353,958,586.25-225,238,140.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金736,84019,920,0003,062,5002,757,500
  其中:子公司吸收少数股东投资收到的现金736,84019,920,0003,062,5002,757,500
  取得借款收到的现金1,388,219,841.141,847,668,5791,418,800,0791,039,000,079
  收到其他与筹资活动有关的现金502,657.92101,258,978.2481,254,122.9280,760,129.99
  筹资活动现金流入小计1,389,459,339.061,968,847,557.241,503,116,701.921,122,517,708.99
  偿还债务支付的现金610,342,072.11,961,053,044.11,254,504,826.54806,502,886.48
  分配股利、利润或偿付利息支付的现金50,410,514.07546,247,131.43512,913,054.6859,419,044.05
  其中:子公司支付给少数股东的股利、利润23,816,627.615,538,427.7715,538,427.77-
  支付其他与筹资活动有关的现金159,230,901.5189,709,737.18148,123,308.03125,939,959.24
  筹资活动现金流出小计819,983,487.672,697,009,912.711,915,541,189.25991,861,889.77
  筹资活动产生的现金流量净额569,475,851.39-728,162,355.47-412,424,487.33130,655,819.22
四、汇率变动对现金及现金等价物的影响-81,778.15-75,142.76-8,302.28-9,965.41
五、现金及现金等价物净增加额384,311,425.47387,517,427.0448,700,536.85864,376,072.22
  加:期初现金及现金等价物余额1,205,284,719.28817,532,973.76817,532,973.76817,532,973.76
  期末现金及现金等价物余额1,589,596,144.751,205,050,400.8866,233,510.611,681,909,045.98
补充资料:
  净利润-192,297,553.48-590,229,183.85
  资产减值准备-527,219,503.79--2,601,071.04
  固定资产和投资性房地产折旧-426,785,324.47-238,530,337.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-426,785,324.47-238,530,337.57
  无形资产摊销-75,440,863.37-35,983,601.66
  长期待摊费用摊销-7,301,389.01-3,560,690.63
  处置固定资产、无形资产和其他长期资产的损失--156,484.37--157,220.65
  固定资产报废损失-745,945.05-102,363.27
  公允价值变动损失-279,493,363.52--3,377,528.63
  财务费用-113,863,697.97-56,721,190.73
  投资损失-3,840,753.16--4,570,467.9
  递延所得税-33,649,814.19-60,949,217.4
  其中:递延所得税资产减少-42,256,340.1-59,565,437.4
    递延所得税负债增加--8,606,525.91-1,383,780
  存货的减少--42,804,237.71-250,177,979.49
  经营性应收项目的减少--684,542,618.54-103,427,131.93
  经营性应付项目的增加-226,921,942.02--341,597,921.31
  现金的期末余额-1,205,050,400.8-1,681,909,045.98
  减:现金的期初余额-817,532,973.76-817,532,973.76
  现金及现金等价物的净增加额-387,517,427.04-864,376,072.22
公告日期2026-04-282026-04-282025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑